Grifols SA ADS (GRFS)

[green maschine]

Plasma donations dropped drastically during the pandemic and is now recovering.
The plasma industry is a very lucrative business which pays the donors $30 - $50 for 880ml of plasma if not donated for free. That same 880ml bottle is then sold to biotechs for $1,000+ for R&D and manufacturing of pharmaceutical products. This company was founded in 1940 and is involved in all aspects of plasma - from donation centers to final products.

"The company's products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. Grifols, S.A. has collaboration agreements with Canadian Blood Services for the processing of other plasma-derived products, and with GIANT and GigaGen to develop recombinant polyclonal immunoglobulin therapies."

https://www.marketbeat.com/stocks/NASDAQ/GRFS/